Track market-moving stories before they get noisy

ATLANTA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI), a global leader in nuclear waste management and environmental remediation solutions, announced today the formation of a strategic Partnership with Mirion Technologies, under the Small Business Administration’s Mentor-Protégé Program.

The formation of the strategic partnership reinforces Perma-Fix’s leadership in the U.S. nuclear cleanup market in support of the Department of Energy (DOE) and its Office of Environmental Management’s mission to reduce risks from the Cold War nuclear legacy and advance safe, permanent solutions for complex radioactive and hazardous waste.

“This Partnership represents a natural evolution of Perma-Fix’s strategy to expand our leadership across the DOE environmental management landscape. As cleanup missions continue to grow in complexity, we believe customers increasingly value solutions that combine specialized treatment infrastructure, radiological expertise, and disciplined execution. Perma-Fix’s waste management and remediation capabilities are the cornerstone of this Partnership, and Mirion’s instrumentation expertise further strengthens our ability to compete for and support larger, more technically demanding cleanup opportunities,” said Mark Duff, President and Chief Executive Officer of Perma-Fix.

The Perma-Fix and Mirion Technologies partnership will leverage Perma-Fix’s more than 30 years of experience in nuclear waste treatment, environmental remediation, project management, and waste disposition, complemented by Mirion Technologies’ expertise in radiation detection, measurement, monitoring, and advanced nuclear instrumentation. The Partnership will focus on opportunities involving advanced waste characterization and segregation, radiological measurement and non-destructive assay, waste processing, packaging, transportation, and disposal support for complex nuclear and environmental remediation projects. Together, the Partnership is intended to support earlier and more accurate waste segregation, optimized disposal pathways, reduced disposal costs and timelines, and improved project execution across major DOE cleanup programs.

The Mentor-Protégé relationship aligns with Perma-Fix’s broader strategy of expanding its participation in long-duration nuclear cleanup and waste treatment programs. As the Company continues to invest in treatment capacity, permitting, and operational readiness across its nuclear platform, management believes strategic partnerships such as this can further strengthen Perma-Fix’s ability to address emerging federal remediation opportunities, including longstanding experience at key DOE facilities such as Los Alamos National Laboratory.

About Perma-Fix Environmental Services

Perma-Fix Environmental Services, Inc. is a nuclear services company and leading provider of nuclear and mixed waste management services. The Company’s nuclear waste services include management and treatment of radioactive and mixed waste for hospitals, research labs and institutions, federal agencies including the DOE, the U.S. Department of War (DOW), and the commercial nuclear industry. The Company’s nuclear services group provides project management, waste management, environmental restoration, decontamination and decommissioning, new build construction, and radiological protection, safety and industrial hygiene capability to its clients. The Company operates four nuclear waste treatment facilities and provides nuclear services at DOE, DOW, and commercial facilities nationwide. Visit us at www.perma-fix.com to learn more.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the agreement described herein, the anticipated benefits and opportunities arising from such agreement, and its potential future impacts. These forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such statements. Further information regarding risks, uncertainties, and other factors that could affect each company’s respective financial results and operations is included in the filings of Mirion Technologies and Perma-Fix Environmental Services, respectively, with the United States Securities and Exchange Commission (the “SEC”), including each company’s respective Annual Reports on Form 10-K and most recent Quarterly Report on Form 10-Q, as well as other periodic reports filed or to be filed with the SEC.

You should not rely on these forward-looking statements, as actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of such risks and uncertainties. All forward-looking statements in this press release are based on information available to each of us as of the date hereof, and neither of us assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

Contacts

For Perma-Fix inquiries:
David K. Waldman – U.S. Investor Relations
Crescendo Communications, LLC
(212) 671-1021

Herbert Strauss – European Investor Relations
[email protected]
+43 316 296 316

For Mirion Technologies media inquiries:
Erin Schesny
[email protected]

For Mirion Technologies investor inquiries:
Eric Linn
[email protected]

Mirion Technologies, Inc. (MIR) Q2 2026 Earnings Call July 29, 2026 10:00 AM EDT

Company Participants

Eric Linn - Vice President of Investor Relations
Thomas Logan - Founder, Medical Group President, CEO & Chairman
Brian Schopfer - CFO & Medical Group President

Conference Call Participants

James West - Melius Research LLC
Joseph Ritchie - Goldman Sachs Group, Inc., Research Division
Quinn Fredrickson - Robert W. Baird & Co. Incorporated, Research Division
Andrew Kaplowitz - Citigroup Inc., Research Division
Christopher Moore - CJS Securities, Inc.
Jeffrey Grampp - Northland Capital Markets, Research Division
Tomohiko Sano - JPMorgan Chase & Co, Research Division

Presentation

Operator

Greetings. Welcome to the Mirion Technologies Second Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note, this conference is being recorded.

I will now turn the conference over to Eric Linn, Treasurer and Head of Investor Relations. Thank you. Eric, you may begin.

Eric Linn
Vice President of Investor Relations

Thank you, Liz, and good morning, everyone. Welcome to Mirion's Second Quarter 2026 Earnings Conference Call. Joining me this morning are Mirion's Founder, Chairman and CEO, Tom Logan; and Mirion's CFO and Medical Group President, Brian Schopfer.

Before we begin today's prepared remarks, allow me to remind you that comments made during this call will include forward-looking statements, and actual results may differ materially from those projected in the forward-looking statements. The factors that could cause actual results to differ are discussed in our annual reports on Form 10-K, quarterly reports on Form 10-Q and in Mirion's other SEC filings under the caption Risk Factors. Quarterly references within today's discussion are related to the second quarter ended June 30, 2026, unless otherwise noted.

The comments made during this call will also include certain financial measures that were not prepared in accordance with generally accepted accounting principles. Reconciliation of those non-GAAP financial measures to the

For the quarter ended June 2026, Mirion Technologies, Inc. (MIR - Free Report) reported revenue of $266.8 million, up 19.7% over the same period last year. EPS came in at $0.12, compared to $0.11 in the year-ago quarter.

The reported revenue represents a surprise of -1.81% over the Zacks Consensus Estimate of $271.72 million. With the consensus EPS estimate being $0.10, the EPS surprise was +20%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Mirion Technologies performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Revenues- Nuclear & Safety: $186.2 million versus the three-analyst average estimate of $188.19 million.Revenues- Medical: $80.6 million versus the three-analyst average estimate of $81.89 million.Adjusted EBITDA- Corporate & Other: $-16.8 million versus $-17.58 million estimated by two analysts on average.Adjusted EBITDA- Medical: $31.1 million versus $30.35 million estimated by two analysts on average.Adjusted EBITDA- Nuclear & Safety: $51 million compared to the $50.26 million average estimate based on two analysts.View all Key Company Metrics for Mirion Technologies here>>>

Shares of Mirion Technologies have returned -3.5% over the past month versus the Zacks S&P 500 composite's +1.7% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Investors in Mirion Technologies, Inc. (MIR - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 20, 2026 $2.5 Call had some of the highest implied volatility of all equity options today.

What isImplied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?Clearly, options traders are pricing in a big move for Mirion Technologies shares, but what is the fundamental picture for the company? Currently, Mirion Technologies is a Zacks Rank #4 (Sell) in the Technology Services industry that ranks in the Top 38% of our Zacks Industry Rank. Over the last 60 days, one analyst has increased the earnings estimates for the current quarter, while none dropped the estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter from 11 cents per share to 10 cents in that period.

Given the way analysts feel about Mirion Technologies right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

The U.S. nuclear sector advanced on two fronts in recent days. Advanced microreactors completed a key federal target while the existing commercial fleet signed a landmark agreement with a major retailer. These moves show momentum at both the innovation edge and the operating base.

Key Takeaways Deployable Energy’s Unity microreactor reached criticality at Idaho National Laboratory. This completed the third advanced reactor demonstration under a presidential executive order. Constellation Energy (CEG) signed a long-term power purchase agreement to supply electricity from one of its reactors in Illinois to a Walmart (WMT) distribution center. Companies in the nuclear fuel and manufacturing supply chains are positioned to support both rapid advanced reactor testing and uprates at operating plants. Microreactors Complete President’s Executive Order Target Deployable Energy achieved criticality with its Unity microreactor at Idaho National Laboratory. This marks the third advanced microreactor to reach this state in recent months. We went into further detail last month, when the first reactor obtained criticality, regarding what this means:

Read further: Critical Momentum: The Nuclear Renaissance Heats Up

It fulfills President Trump’s May 2025 executive order. The order set a goal for three advanced reactors to attain criticality by July 4, 2026. Antares Nuclear and Valar Atomics completed the first two criticalities in June. These fast timelines highlight the effectiveness of the DOE Reactor Pilot Program. 

With the program enabling the achievement of the executive order goal, the nuclear industry demonstrates significant potential. The success of the bleeding edge of advanced nuclear technology unlocks the potential for significant supply chain capacity expansion.

Companies including BWX Technologies (BWXT) and Mirion Technologies (MIR) are deeply integrated to supply fuel and instrumentation for the development of these microreactors.

Existing Fleet Expands to New Retail Customer Constellation announced a long-term agreement with Walmart. The deal supplies power from the Dresden Clean Energy Center in Illinois. Dresden hosts two boiling water nuclear reactors. 

The power purchase agreement includes support for uprates that boost output from the existing reactor units. The agreement covers approximately 176 megawatts of capacity for supplying power to Walmart’s high-tech distribution center in Belvidere. 

This represents one of the first nuclear power purchase agreements for a major retailer. The structure extends reliable, carbon-free baseload power beyond typical hyperscale data centers or heavy industrial users. Uprates at operating plants increase generation without new construction, and support long-term reliability and local economic activity. 

NUKZX Captures Both Ends of the Spectrum The VettaFi Nuclear Renaissance Index (NUKZX) includes companies positioned for both developments. NUKZX offers exposure across the nuclear value chain to include companies in fuel supply sectors such as BWXT and GE Vernova (GEV). Companies including FlowServe (FLS) and MIR are also positioned to benefit from the recent significant support pledged by the Department of Energy:

Read further: DOE’s $17.5B Loan Boosts Nuclear Supply Chain

These firms generate revenue from accelerated demonstration programs. They also benefit from capital spending on existing plant enhancements. NUKZX serves as the underlying index for the Range Nuclear Renaissance Index ETF (NUKZ). Investors gain diversified exposure to the full nuclear value chain through this structure.

Related Research: DOE’s $17.5B Loan Boosts Nuclear Supply Chain

Critical Momentum: The Nuclear Renaissance Heats Up

The Geopolitical Bull Case for Nuclear

Looking for nuclear insights in your inbox? Subscribe here to keep a pulse on nuclear investing through our weekly research.

For more news, information, and analysis, visit the Nuclear Energy Content Hub.

vettafi.com is owned by VettaFi LLC (“VettaFi”). VettaFi is the index provider for NUKZ, for which it receives an index licensing fee. However, NUKZ is not issued, sponsored, endorsed, or sold by VettaFi. VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of NUKZ

Bamco Inc. NY acquired a new stake in shares of Mirion Technologies, Inc. (NYSE: MIR) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 500,000 shares of the company's stock, valued at approximately $11,630,000. Bamco Inc. NY owned 0.20% of Mirion Technologies

-

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for first quarter 2026 after market close on Tuesday, April 28, 2026. Following the news release, the company will host a conference call the next day, Wednesday, April 29, 2026, at 10:00 am ET to discuss the results.

Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events.

A telephonic replay will be available shortly after the conclusion of the call and until May 13, 2026. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with access code 13760000. An archived replay of the call will also be available on the Investors portion of the Mirion website at https://ir.mirion.com/.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Nuclear & Safety group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 3,200 people and operates in 12 countries. Learn more at mirion.com.

More News From Mirion Technologies, Inc.

Back to Newsroom

ATLANTA--(BUSINESS WIRE)--Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced results for the first quarter ended March 31, 2026.

“Our first quarter performance showcased substantial orders growth led by nuclear power demand and as-expected Adjusted EBITDA performance and margins,” commented Mirion’s Chairman and Chief Executive Officer Thomas Logan. “Record capital spending commitments by power plant operators are driving accelerating momentum in the sector, which is translating into significant Nuclear Power demand.”

Logan continued, “Our strong performance also reflects Paragon’s contributions in its first full quarter with Mirion. Paragon is the ‘tip of the spear’ for growing installed base dynamics. Integration is on-pace, and we are already realizing commercial synergies.”

2026 Guidance

Commenting on Mirion’s full year 2026 guidance, Logan said, “We remain on track for 2026 revenue growth, Organic Revenue growth, Adjusted EBITDA, and Adjusted Free Cash Flow guidance. Our business continues to capture momentum in Nuclear Power and Cancer Care markets. Additionally, we are bringing new products to market and enhancing our current offerings to meet customers where they are headed.”

Mirion reaffirmed 2026 total revenue growth, Organic Revenue growth, Adjusted EBITDA, and Adjusted Free Cash Flow guidance for the fiscal year ending December 31, 2026, while revising Adjusted EPS guidance to reflect the impact of a special one-time CEO retention grant of performance vesting stock options disclosed on April 13, 2026.

Revenue growth of approximately 22.0% – 24.0%; includes foreign exchange rate and acquisition-related tailwinds. Organic Revenue growth of approximately 5.0% – 7.0%. Adjusted EBITDA and Adjusted EBITDA margin of approximately $285 million – $300 million; Adjusted EBITDA margin of approximately 25.0% – 26.0%. Adjusted Free Cash Flow of approximately $155 million – $175 million; Adjusted Free Cash Flow Conversion of approximately 54% – 58% of Adjusted EBITDA. Adjusted EPS of approximately $0.48 – $0.55 per share (previously $0.50 - $0.57 per share); adjusted to reflect the impact of a special one-time CEO retention grant of performance vesting stock options disclosed on April 13, 2026. Additional modeling and guidance assumptions are included in the appendix of the earnings presentation on the Company’s investor relations page.

The Company’s guidance contains forward-looking statements and actual results may differ materially as a result of known and unknown uncertainties and risks, including those set forth below under the heading “Forward-Looking Statements.” In addition, forward-looking non-GAAP financial measures are presented on a non-GAAP basis without reconciliations of such forward-looking non-GAAP measures due to the inherent difficulty in projecting and quantifying the various adjusting items necessary for such reconciliations, such as stock-based compensation expense, amortization and depreciation expense, merger and acquisition activity and purchase accounting adjustments, that have not yet occurred, are out of Mirion’s control, or cannot be reasonably predicted. Accordingly, reconciliations of our guidance for Organic Revenue growth, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EPS, Adjusted Free Cash Flow and Adjusted Free Cash Flow conversion are not available without unreasonable effort.

Conference Call

Mirion will host a conference call tomorrow, April 29, 2026 at 10:00 a.m. ET to discuss its financial results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events.

A telephonic replay will be available shortly after the conclusion of the call and until May 13, 2026. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671, and enter access code 13760000. An archived replay of the call and an accompanying presentation will also be available on the Investors section of the Mirion website at https://ir.mirion.com/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “hope”, “intend”, “may”, “might”, “plan”, “possible”, “potential”, “predict”, “project”, “should”, “strive”, “seeks”, “plans”, “would”, “will”, “understand” and similar words are intended to identify forward-looking statements, but the absence of these words does not mean that a statement is not forward looking. These forward-looking statements include but are not limited to, statements regarding our future operating results, financial position and guidance, our backlog and order potential, our business strategy and plans, our objectives for future operations, macroeconomic trends, trends in cancer care, nuclear power and small modular reactor, foreign exchange, interest rate and inflation expectations and any future mergers, acquisitions, divestitures and strategic investments, including the completion and integration of previously completed transactions. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including changes in domestic and foreign business, market, economic, financial, political and legal conditions, including related to matters affecting Russia, the relationship between the United States and China, conflict in the Middle East (including the U.S.-Israel-Iran conflict), tariffs or other trade and supply chain disruptions, and risks of slowing economic growth or economic recession in the United States and globally; developments in the government budgets (defense and non-defense) in the United States and other countries, including budget reductions, sequestration, implementation of spending limits or changes in budgetary priorities, delays in the government budget process, a U.S. government shutdown or the U.S. government’s failure to raise the debt ceiling; risks related to the public’s perception of nuclear radiation and nuclear technologies; risks related to the continued growth of our end markets; our ability to win new customers and retain existing customers; our ability to realize sales expected from our backlog of orders and contracts; risks related to governmental contracts; our ability to mitigate risks associated with long-term fixed price contracts, including risks related to inflation; risks related to information technology system failures or other disruptions or cybersecurity, data security or other security threats; risks related to the implementation and enhancement of information systems; our ability to manage our supply chain or difficulties with third-party manufacturers; risks related to competition; our ability to manage disruptions of, or changes in, our independent sales representatives, distributors and original equipment manufacturers; our ability to realize the expected benefit from strategic transactions, such as acquisitions, divestitures, investments and partnerships, including any synergies, or internal restructuring and improvement efforts; our ability to issue debt, equity or equity-linked securities in the future; risks related to changes in tax law and ongoing tax audits; risks related to future legislation and regulation both in the United States and abroad; risks related to the costs or liabilities associated with product liability claims; risks related to the uncertainty of legal claims, litigation, arbitration and similar proceedings; our ability to attract, train and retain key members of our leadership team and other qualified personnel; risks related to the adequacy of our insurance coverage; risks related to the global scope of our operations, including operations in international and emerging markets; risks related to our exposure to fluctuations in foreign currency exchange rates, interest rates and inflation, including the impact on our debt service costs; our ability to comply with various laws and regulations and the costs associated with legal compliance; risks related to the outcome of any litigation, government and regulatory proceedings, investigations and inquiries; risks related to our ability to protect or enforce our proprietary rights on which our business depends or third-party intellectual property infringement claims; liabilities associated with environmental, health and safety matters; our ability to predict our future operational results; and the effects of health epidemics, pandemics and similar outbreaks may have on our business, results of operations or financial condition. Further information on risks, uncertainties and other factors that could affect our financial results are included in the filings we make with the United States Securities and Exchange Commission (the “SEC”) from time to time, including our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and other periodic reports filed or to be filed with the SEC.

You should not rely on these forward-looking statements, as actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of such risks and uncertainties. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

Use of Non-GAAP Financial Information

In addition to our results determined in accordance with GAAP, we believe that the presentation of non-GAAP financial information provides important supplemental information to management and investors regarding financial and business trends relating to our financial condition and results of operations. For further information regarding these non-GAAP measures, including the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures, please refer to the financial tables below, as well as the “Reconciliation of Non-GAAP Financial Measures” section of this press release. Non-GAAP financial information is not a substitute for GAAP financial information and undue reliance should not be placed on such non-GAAP financial information. In addition, similarly titled items used by other companies may not be comparable due to variations in how they are calculated and how terms are defined.

Channels for Disclosure of Information

Mirion intends to announce material information to the public through the Mirion Investor Relations website ir.mirion.com, SEC filings, press releases, public conference calls and public webcasts. Mirion uses these channels, as well as social media, to communicate with its investors, customers, and the public about the company, its offerings, and other issues. It is possible that the information Mirion posts on social media could be deemed to be material information. As such, Mirion encourages investors, the media, and others to follow the channels listed above, including the social media channels listed on Mirion’s investor relations website, and to review the information disclosed through such channels. Any updates to the list of disclosure channels through which Mirion will announce information will be posted on the investor relations page on Mirion’s website.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Nuclear & Safety group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at mirion.com.

  Mirion Technologies, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(In millions, except share data)

March 31, 2026

December 31, 2025

ASSETS

Current assets:

Cash and cash equivalents

$

397.9

$

412.3

Accounts receivable, net of allowance for doubtful accounts

181.5

181.6

Costs in excess of billings on uncompleted contracts

98.9

93.8

Inventories

157.9

152.6

Prepaid expenses and other current assets

54.7

53.4

Total current assets

890.9

893.7

Property, plant, and equipment, net

152.6

154.9

Operating lease right-of-use assets

30.8

32.1

Goodwill

1,860.4

1,872.4

Intangible assets, net

576.0

606.3

Other assets

25.2

28.7

Total assets

$

3,535.9

$

3,588.1

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$

66.1

$

57.4

Deferred contract revenue

108.1

112.3

Debt, current

1.6

1.6

Operating lease liability, current

7.7

7.7

Derivative liabilities, current

—

20.7

Accrued expenses and other current liabilities

95.7

116.4

Total current liabilities

279.2

316.1

Debt, non-current

443.5

443.1

Convertible debt

755.6

754.5

Operating lease liability, non-current

25.5

26.8

Deferred income taxes, non-current

68.1

70.0

Other liabilities

75.5

60.7

Total liabilities

1,647.4

1,671.2

Commitments and contingencies (Note 11)

Stockholders’ equity (deficit):

Class A common stock; $0.0001 par value, 500,000,000 shares authorized; 244,395,666 shares issued and outstanding at March 31, 2026; 244,662,792 shares issued and outstanding at December 31, 2025

—

—

Class B common stock; $0.0001 par value, 100,000,000 shares authorized; 5,864,555 shares issued and outstanding at March 31, 2026; 5,869,555 shares issued and outstanding at December 31, 2025

—

—

Treasury stock, at cost; 4,376,586 shares at March 31, 2026 and 3,492,619 shares December 31, 2025

(78.1

)

(58.4

)

Additional paid-in capital

2,495.1

2,490.1

Accumulated deficit

(516.1

)

(512.7

)

Accumulated other comprehensive loss

(62.6

)

(52.6

)

Mirion Technologies, Inc. stockholders’ equity

1,838.3

1,866.4

Noncontrolling interests

50.2

50.5

Total stockholders’ equity

1,888.5

1,916.9

Total liabilities and stockholders’ equity

$

3,535.9

$

3,588.1

Mirion Technologies, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(In millions, except per share data)

  Three Months Ended
March 31, 2026

Three Months Ended
March 31, 2025

Revenues:

Product

$

197.0

$

147.9

Service

60.6

54.1

Total revenues

257.6

202.0

Cost of revenues:

Product

112.9

81.7

Service

25.6

24.2

Total cost of revenues

138.5

105.9

Gross profit

119.1

96.1

Operating expenses:

Selling, general and administrative

105.8

78.7

Research and development

9.6

8.7

Total operating expenses

115.4

87.4

Income from operations

3.7

8.7

Other expense (income):

Interest expense

8.4

12.5

Interest income

(3.4

)

(1.9

)

Foreign currency loss (gain), net

3.7

(2.8

)

Other expense, net

0.2

0.3

(Loss) income before income taxes

(5.2

)

0.6

Income tax (benefit) expense

(1.8

)

0.2

Net (loss) income

(3.4

)

0.4

Income attributable to noncontrolling interests

—

0.1

Net (loss) income attributable to Mirion Technologies, Inc.

$

(3.4

)

$

0.3

(Loss) earnings per common share attributable to Mirion Technologies, Inc.:

Basic

$

(0.01

)

$

0.00

Diluted

$

(0.01

)

$

0.00

Weighted average common shares outstanding:

Basic

244.663

225.655

Diluted

244.663

226.918

Mirion Technologies, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

(In millions)

  Three Months Ended
March 31, 2026

Three Months Ended
March 31, 2025

OPERATING ACTIVITIES:

Net (loss) income

$

(3.4

)

$

0.4

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization expense

40.8

33.7

Stock-based compensation expense

4.3

3.4

Amortization of debt issuance costs

1.5

0.9

Provision for doubtful accounts

0.6

0.7

Inventory obsolescence write down

0.3

0.5

Change in deferred income taxes

(2.6

)

(5.7

)

Loss on disposal of property, plant and equipment

0.1

0.1

(Gain) loss on foreign currency transactions

3.7

(2.8

)

Amortization of inventory step-up

0.8

—

Changes in operating assets and liabilities:

Accounts receivable

(1.8

)

31.1

Costs in excess of billings on uncompleted contracts

(4.7

)

(2.1

)

Inventories

(6.5

)

(8.3

)

Prepaid expenses and other current assets

(1.9

)

(0.5

)

Accounts payable

9.9

(2.3

)

Accrued expenses and other current liabilities

(19.6

)

(5.7

)

Deferred contract revenue and liabilities

(4.2

)

(4.4

)

Other assets

(0.2

)

0.3

Other liabilities

1.8

(3.7

)

Net cash provided by operating activities

18.9

35.6

INVESTING ACTIVITIES:

Purchases of property, plant, and equipment and badges

(9.5

)

(8.5

)

Proceeds from net investment hedge derivative contracts

0.3

0.9

Net cash used in investing activities

(9.2

)

(7.6

)

FINANCING ACTIVITIES:

Stock repurchased to satisfy tax withholding for vesting restricted stock units

(4.1

)

(1.9

)

Purchases of stock for treasury

(16.0

)

(18.6

)

Financing costs

—

(0.5

)

Proceeds from cash flow hedge derivative contracts

0.1

0.1

Other financing

0.1

(0.3

)

Net cash used in financing activities

(19.9

)

(21.2

)

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

(4.2

)

3.8

Net (decrease) increase in cash, cash equivalents, and restricted cash

(14.4

)

10.6

Cash, cash equivalents, and restricted cash at beginning of period

415.2

175.6

Cash, cash equivalents, and restricted cash at end of period

$

400.8

$

186.2

  Share Count

244,395,666 shares of Class A common stock were outstanding as of March 31, 2026. This excludes (1) 5,864,555 shares of Class B common stock outstanding as of March 31, 2026, (2) 1,068,248 shares of Class A common stock underlying restricted stock units and 2,055,997 shares of Class A common stock underlying performance stock units; and (3) any other shares issuable from future equity awards under our 2021 Omnibus Incentive Plan, which had 45,800,089 shares reserved (subject to annual automatic increases) as of March 31, 2026. The 5,864,555 shares of Class B common stock are paired on a one-for-one basis with shares of Class B common stock of Mirion Intermediate Co., Inc. (the "paired interests"). Holders of the paired interests have the right to have their interests redeemed for, at the option of Mirion, shares of Class A common stock on a one-for-one basis or cash based on a trailing stock price average. All share data is as of March 31, 2026, unless otherwise noted.

Reconciliation of Non-GAAP Financial Measures

In addition to our results determined in accordance with GAAP, we believe the following non-GAAP measures are useful in evaluating our operating performance. We use the following non-GAAP financial information to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that non-GAAP financial information, when taken collectively, may be helpful to investors because it provides consistency and comparability with past financial performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Other companies, including companies in our industry, may calculate similarly titled non-GAAP measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison.

Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures and not rely on any single financial measure to evaluate our business.

Organic revenues is defined as Revenues excluding the impact of foreign exchange rates as well as mergers, acquisitions and divestitures in the period.

Adjusted EBITDA is defined as net income before interest expense, income tax expense, depreciation and amortization adjusted to remove the impact of foreign currency gains and losses, amortization of acquired intangible assets, changes in the fair value of warrants, certain non-operating expenses (restructuring and costs to achieve operational synergies, merger, acquisition and divestiture expenses and IT project implementation expenses), stock-based compensation expense, debt extinguishment and income tax impacts of these adjustments.

Adjusted EBITDA margin is defined as Adjusted EBITDA divided by Revenue.

Adjusted net income is defined as GAAP net income adjusted for foreign currency gains and losses, amortization of acquired intangible assets, changes in the fair value of warrants, certain non-operating expenses (restructuring and costs to achieve operational synergies, merger, acquisition and divestiture expenses and IT project implementation expenses), stock-based compensation expense, debt extinguishment and income tax impacts of these adjustments.

Adjusted EPS is defined as adjusted net income divided by weighted average common shares outstanding — basic and diluted.

Adjusted Free Cash Flow is defined as free cash flow adjusted to include the impact of cash used to fund non-operating expenses. We believe that the inclusion of supplementary adjustments to free cash flow applied in presenting adjusted free cash flow is appropriate to provide additional information to investors about our cash flows that management utilizes on an ongoing basis to assess our ability to generate cash for use in acquisitions and other investing and financing activities.

Adjusted Free Cash Flow Conversion is defined as adjusted free cash flow divided by adjusted EBITDA.

Free cash flow is defined as U.S. GAAP net cash provided by operating activities adjusted to include the impact of purchases of property, plant, and equipment, purchases of badges and proceeds from derivative contracts.

Net leverage is defined as Net Debt (debt minus cash and cash equivalents) divided by Adjusted EBITDA plus contributions to Adjusted EBITDA if acquisitions made during the applicable period had been made before the start of the applicable period.

Operating Metrics

Order and orders growth are defined as the amount of revenue earned in a given period and estimated to be earned in future periods from contracts entered into in a given period as compared with such amount for a prior period. Foreign exchange rates are based on the applicable rates as reported for the time period.

The following tables present reconciliations of certain non-GAAP financial measures for the applicable periods.

  Mirion Technologies, Inc.

Reconciliation of Adjusted EBITDA

(In millions)

  Three Months Ended

March 31,

2026

2025

Income from operations

$

3.7

$

8.7

Amortization

31.0

25.4

Depreciation

9.8

8.3

Stock-based compensation

4.3

3.4

Cost of revenues impact from inventory valuation purchase accounting

0.8

—

Non-operating expenses

4.9

1.2

Other expense / income

(0.2

)

(0.3

)

Adjusted EBITDA

$

54.3

$

46.7

Income from operations margin

1.4

%

4.3

%

Adjusted EBITDA margin

21.1

%

23.1

%

Mirion Technologies, Inc.

Reconciliation of Adjusted Earnings per Share

(In millions, except per share values)

  Three Months Ended

March 31,

2026

2025

Net (loss) income attributable to Mirion Technologies, Inc.

$

(3.4

)

$

0.3

Income attributable to non-controlling interests

—

0.1

GAAP net (loss) income

$

(3.4

)

$

0.4

Foreign currency loss (gain), net

3.7

(2.8

)

Amortization of acquired intangibles

31.0

25.4

Stock-based compensation(1)

—

3.4

Cost of revenues impact from inventory valuation purchase accounting

0.8

—

Non-operating expenses

4.9

1.2

Tax impact of adjustments above

(10.3

)

(5.2

)

Adjusted net income

$

26.7

$

22.4

Weighted average common shares outstanding — basic

244.663

225.655

Dilutive potential common shares - stock-based awards

0.589

1.263

Dilutive potential common shares - convertible debt

30.321

—

Adjusted weighted average common shares — diluted

275.573

226.918

GAAP loss per share

$

(0.01

)

$

—

Adjusted earnings per share

$

0.10

$

0.10

(1) The calculation for adjusted net income has been adjusted for the current period to include stock-based compensation.

More News From Mirion Technologies, Inc.

Mirion Technologies, Inc. (MIR - Free Report) reported $257.6 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 27.5%. EPS of $0.10 for the same period compares to $0.10 a year ago.

The reported revenue represents a surprise of +3.89% over the Zacks Consensus Estimate of $247.95 million. With the consensus EPS estimate being $0.10, the company has not delivered EPS surprise.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Mirion Technologies performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Revenues- Nuclear & Safety: $185.5 million compared to the $182.54 million average estimate based on two analysts.Revenues- Medical: $72.1 million versus the two-analyst average estimate of $71.35 million.Adjusted EBITDA- Medical: $24.6 million compared to the $24.68 million average estimate based on two analysts.Adjusted EBITDA- Corporate & Other: $-17.1 million versus $-18.35 million estimated by two analysts on average.Adjusted EBITDA- Nuclear & Safety: $46.8 million versus the two-analyst average estimate of $51.65 million.View all Key Company Metrics for Mirion Technologies here>>>

Shares of Mirion Technologies have returned +11.1% over the past month versus the Zacks S&P 500 composite's +12.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Key Takeaways BWX Technologies and Mirion are gaining from rising nuclear demand tied to AI-driven energy needs.BWXT is expanding via acquisitions and uranium enrichment plans to boost capacity and meet demand.Mirion posted strong Q1 growth and secured a role in NASA's Artemis II mission with radiation tech. Mirion Technologies (MIR - Free Report) and BWX Technologies (BWXT - Free Report) are drawing strong investor interest as nuclear energy gains momentum. The sector is increasingly in focus due to the rapid expansion of Artificial Intelligence (AI)-driven data centers, which require large amounts of energy to operate. This growing power demand is positioning nuclear energy as one of the fastest-growing and most talked-about industries today.

Mirion focuses on radiation detection, measurement and monitoring solutions. It serves customers across North America, Europe and the Asia-Pacific region, with applications in healthcare, defense and nuclear safety.

BWX Technologies manufactures and supplies nuclear components and fuel. The company plays an important role in supporting both defense programs and commercial nuclear power projects in the United States, Canada and other international markets.

Both companies are benefiting from the growing focus on clean and reliable energy sources. However, they also face challenges such as regulatory requirements, project delays and cost pressures.

With this background, let’s take a closer look at their fundamentals, growth opportunities and key risks.

Tailwinds for MIRMIR is benefiting from strong operational performance and growing demand for its radiation safety solutions, which are supporting investor confidence. In April 2026, the company reported solid first-quarter results, with sales rising 27.5% year over year and adjusted earnings per share increasing 11.1%, reflecting steady business momentum.

In March 2026, Mirion highlighted a major milestone as its advanced radiation monitoring technology was selected for Artemis II. The company’s Crew Active Dosimeters (CAD) will be carried by astronauts during the mission, providing real-time radiation exposure data. This achievement underscores Mirion’s strong position in high-reliability applications, particularly in space and defense.

Artemis II, led by NASA, will be a roughly 10-day mission around the Moon and represents a key step in future deep-space exploration. Mirion’s involvement not only highlights the importance of its technology in ensuring astronaut safety but also strengthens its growth prospects in advanced and mission-critical environments.

Tailwinds for BWXTBWXT is benefiting from strategic expansion efforts and rising demand for nuclear energy, which are strengthening its long-term growth outlook. In April 2026, the company announced a definitive agreement to acquire Precision Components Group (“PCG”), including its subsidiaries Precision Custom Components (PCC) and DC Fabricators (DCF). This acquisition is expected to expand BWXT’s heavy manufacturing capabilities and increase its commercial nuclear production capacity in the United States, helping it better serve growing domestic demand.

In another key development in April, BWXT informed the U.S. Nuclear Regulatory Commission (NRC) of its plans to apply for a uranium enrichment license. The proposed facility will be located near its Nuclear Fuel Services site in Erwin, TN, and is expected to support future fuel supply needs. The company plans to submit the license application in early 2027.

These initiatives highlight BWXT’s focus on expanding its capabilities and strengthening its position in the nuclear energy market, particularly as demand for reliable and clean energy continues to grow.

How Does the Zacks Consensus Estimate Compare for MIR & BWXT?The Zacks Consensus Estimate for MIR’s 2026 sales and EPS implies a year-over-year improvement of 22.7% and 19.6%, respectively.  EPS estimates for 2026 have moved north over the past 60 days.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for BWXT’s 2026 sales and EPS implies a year-over-year improvement of 17.3% and 14.7%, respectively. EPS estimates for 2026 and 2027 have been trending northward over the past 60 days.

Image Source: Zacks Investment Research

Stock Price Performance: BWXT & MIRIn the past year, BWXT has outperformed MIR. While BWXT’s shares surged 87.3%, MIR surged 18.5%.

Image Source: Zacks Investment Research

Valuation for BWXT & MIRMIR is trading at a forward sales multiple (P/S F12M) of 4.02, below BWXT’s forward sales multiple of 4.94.

Image Source: Zacks Investment Research

BWXT & MIR’s Return on Equity (ROE)ROE measures how efficiently a company is utilizing its shareholders’ funds to generate profits. BWXT’s current ROE is 30.94% compared with MIR’s 6.55%.

End NoteWhile both Mirion and BWX Technologies are well-positioned to benefit from rising demand for nuclear energy, the latter currently stands out in several key areas. The company has delivered a stronger stock price performance over the past year and continues to show solid profitability, supported by a higher return on equity and an improving earnings outlook.

BWXT is also actively expanding its capabilities through acquisitions and new facility plans, which could support long-term growth. Meanwhile, Mirion is showing steady operational momentum and remains well placed in niche, high-reliability markets like space and radiation safety.

Considering these factors, BWXT appears to be the stronger pick at the moment, although both companies offer exposure to the growing nuclear energy space.

Both BWXT and MIR currently carry a Zacks Rank #2 (Buy).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The nuclear industry has seen a recent flurry of announcements, headlined by two major industry partnerships to rapidly deploy new reactors. These exciting developments come against the backdrop of a new national poll showing increased positive sentiment towards nuclear energy. This all adds to the positive tailwinds for nuclear development in the U.S.

Brookfield Asset Management (BAM) and The Nuclear Company (TNC, private) have formed a new partnership to deploy Westinghouse AP1000 and AP300 reactors, while Blue Energy (private) has teamed with GE Vernova (GEV) to pioneer a gas-plus-nuclear hybrid approach. These developments arrive as a new Gallup poll revealed record public support for nuclear energy alongside declining enthusiasm for solar and wind. Together, the announcements highlight how private-sector execution expertise and innovative deployment models are translating policy momentum and shifting sentiment into tangible project progress.

The VettaFi Nuclear Renaissance Index (NUKZX) provides exposure to companies that will benefit from these tailwinds. The index includes key reactor technology owners, equipment providers, and service firms positioned to generate revenue from these projects. NUKZX serves as the underlying index for the Range Nuclear Renaissance Index ETF (NUKZ).

Brookfield and TNC Target Westinghouse Revival Brookfield, a global infrastructure investment firm with more than $1 trillion in assets under management, has partnered with TNC to create a new nuclear project execution company. TNC was founded by veterans of the Vogtle Units 3 and 4 project in Georgia, which were the last large reactors built in the U.S. The new entity will specialize in end-to-end project management, licensing support, engineering, procurement, construction, and commissioning for Westinghouse’s AP1000 large reactors and the smaller AP300 design.

Dive deeper on Westinghouse’s reactor lineup

TNC looks to utilize the experience of their team from the previous AP1000 projects at the Vogtle nuclear plant to successfully deploy Westinghouse technology across the United States and abroad, starting with South Carolina. 

The partnership has already secured a lead role for the partially completed V.C. Summer AP1000 units in South Carolina. The project was previously abandoned due to significant cost overruns. Subject to due diligence, regulatory approvals, and a final investment decision, the new company will oversee completion of the two units.

This builds directly on the U.S. government’s $80 billion strategic partnership with Brookfield and Cameco (CCJ) to deploy AP1000 technology nationwide. Cameco holds a 49% stake in Westinghouse alongside Brookfield’s 51% ownership. The collaboration leverages TNC’s AI-driven system to deliver projects on predictable timelines and budgets.

Blue Energy and GE Vernova Introduce Gas-Plus-Nuclear Hybrid In parallel, Blue Energy and GE Vernova (GEV) announced a collaboration to build the world’s first gas-plus-nuclear power plant in Texas. The approach pairs GE Vernova’s industry-leading gas turbines for initial power generation with their BWRX-300 small modular reactor (SMR) for long-term baseload output.

Read further on GE Vernova’s SMR design

The hybrid model enables early site energization with approximately 1 gigawatt (GW) of gas-fired power as soon as 2030, followed by the switch to roughly 1.5 GW of nuclear capacity from an array of BWRX-300s as early as 2032. Initial site work is targeted for 2026, with a final investment decision and NRC construction permit application planned for 2027. The plant will supply a nearby data center campus, meeting surging electricity demand from artificial intelligence and advanced manufacturing.

By using a natural-gas bridge and offsite prefabrication of modules, the partnership aims to cut time-to-power in half compared with traditional nuclear timelines while lowering capital costs and avoiding ratepayer burdens. GE Vernova’s BWRX-300 is one of the only SMRs currently under construction in the Western world, and this project further de-risks the technology through resequenced construction phases recently approved by the NRC.

Gallup Poll Reflects Shifting Public Sentiment A Gallup survey released in late April 2026 shows nuclear energy gaining ground with the American public. Support for greater emphasis on nuclear power reached 46%, its highest level in the 13 years Gallup has asked the question, and up seven points since 2021. Nuclear now holds a leading popularity among six major energy sources, including renewables.

By contrast, support for solar and wind dropped to their lowest levels in more than a decade. The narrower partisan divide on nuclear compared with renewables suggests growing bipartisan recognition of nuclear’s role in delivering reliable, dispatchable power. While some local opposition to nearby plants persists, the national trend points to stronger tailwinds for new nuclear development.

Clear Wins Across the NUKZX Value Chain These projects directly benefit NUKZX constituents already embedded in the nuclear supply chain.

Cameco stands to gain through its ownership in Westinghouse and its fuel supply capabilities. GE Vernova benefits as the technology provider for the Texas hybrid plant and as a leader in SMR commercialization.

Engineering, procurement, and construction firms such as Fluor (FLR) are well positioned for the complex project management and site work required. Component and systems providers including Curtiss-Wright (CW) and BWX Technologies (BWXT) supply critical pumps, valves, instrumentation, and fuel-related hardware essential to both large reactors and SMRs. Mirion Technologies (MIR) and other instrumentation specialists also stand to secure orders as construction ramps.

NUKZX includes companies across the full nuclear value chain, from fuel and components to engineering, construction, and utilities. For investors interested in the global growth opportunity for nuclear power, NUKZX offers a diversified group of companies positioned to benefit from the full spectrum of the nuclear renaissance. 

Related Research: Profiling Reactor Technology: Nano Nuclear & GE Vernova

Profiling Reactor Technology: Westinghouse and Oklo

Not All Nuclear Exposure Is Created Equally

From Silicon to Power: AI’s Next Bottleneck

Looking for nuclear insights in your inbox? Subscribe here to keep a pulse on nuclear investing through our weekly research.

For more news, information, and analysis, visit the Nuclear Energy Content Hub.

vettafi.com is owned by VettaFi LLC (“VettaFi”). VettaFi is the index provider for NUKZ, for which it receives an index licensing fee. However, NUKZ is not issued, sponsored, endorsed, or sold by VettaFi. VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of NUKZ.

On May 22, 2026, Mirion Technologies Inc MIR shares rose 4.2% to a current price of $18.35. This increase comes amid a 52-week range of $16.84 to $30.28, reflecting a volatile trading period for the stock.

GF Value™ verdict: Current price is $18.35, which is 40.4% overvalued compared to the GF Value™ of $13.07.GF Score™ is 54/100, indicating an average performance relative to other stocks.Most notable signal: Insiders have sold $0.2M of stock in the last 3 months with no buying activity. Is MIR Overvalued or Undervalued? According to the GF Value™, Mirion Technologies Inc is currently significantly overvalued. The current share price of $18.35 is 40.4% higher than the estimated fair value of $13.07. This substantial premium raises concerns about the stock's margin of safety, suggesting that potential investors may be exposing themselves to heightened risk. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.

The overvaluation indicates that investors are paying a premium for MIR shares, which may not be justified by the company’s current financial performance or growth prospects. As the market adjusts to reflect more realistic value estimates, there could be downward pressure on the stock price, thus cautioning potential investors against entering the stock at this inflated valuation.

How Does MIR's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 203.9x 226.4x Forward P/E 34.1x N/A The current P/E (TTM) of 203.9x is below its 5-year median P/E of 226.4x, indicating that the stock is trading at a relatively lower valuation compared to its historical levels. However, the forward P/E of 34.1x suggests a more optimistic outlook for future earnings, which may not fully align with the GF Value™ verdict. This analysis generally agrees with the GF Value™ assessment, confirming that despite a lower historical P/E, the stock remains overvalued based on intrinsic value calculations.

What Does MIR's GF Score™ Tell Us? Metric Rating GF Score™ 54 Financial Strength 5/10 Profitability 3/10 Growth 0/10 Valuation 5/10 Momentum 5/10 The GF Score™ of 54/100 indicates that Mirion Technologies Inc has a mixed performance across various financial metrics. Its strongest area is Financial Strength, rated at 5/10, while the weakest area is Growth, which is rated at 0/10. The average rating in Valuation and Momentum further underscores the need for caution among potential investors, as the lack of growth may diminish future potential and returns.

What Are Insiders Doing with MIR Stock? Recent insider activity for Mirion Technologies Inc reveals a concerning trend, as insiders have sold $0.2 million worth of shares over the past three months without any buying activity. This selling activity may indicate a lack of confidence among insiders regarding the company's future prospects or current valuation, which could be viewed as a bearish signal for outside investors.

When insiders sell shares, it can often raise red flags regarding the health of the company or its future performance. In this case, the absence of insider buying reinforces the notion of overvaluation and suggests that those closest to the company may not foresee significant upside in the near term.

What This Means for Investors Based on the GF Value™ assessment, Mirion Technologies Inc is currently overvalued with a significant gap between its market price and intrinsic value. This overvaluation, coupled with mixed financial metrics and insider selling, suggests that potential investors should proceed with caution when considering an investment in MIR.

For the complete analysis, visit the Mirion Technologies Inc MIR stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.

Frequently Asked Questions What is MIR's GF Score™?

MIR's GF Score™ is 54/100, indicating an average performance across key metrics, suggesting that while the stock has some strengths, it may not outperform in the long term.

Is MIR overvalued or undervalued?

MIR is currently overvalued with a GF Value™ of $13.07, indicating that the current price of $18.35 presents a significant premium over its estimated intrinsic value.

What is MIR's P/E ratio?

MIR's P/E ratio is 203.9x (TTM), which is below its 5-year median P/E of 226.4x, suggesting a lower valuation relative to its historical average, yet still aligning with the overvaluation indicated by the GF Value™.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

On May 27, 2026, Mirion Technologies Inc MIR shares fell 5.8% today, bringing the current price to $16.96. Over the past year, the stock has experienced a decline of 12.8%, with a year-to-date drop of 27.6%. The stock has traded within a 52-week range of $16.84 to $30.28.

GF Value™ verdict: Current price of $16.96 is 29.3% above GF Value™ of $13.12, indicating that the stock is overvalued.GF Score™ is 54/100, suggesting an average performance based on key financial metrics.Notable signal: Insiders sold $0.2M worth of shares in the last 3 months, indicating a lack of confidence from those within the company. Is MIR Overvalued or Undervalued? Mirion Technologies Inc MIR is currently trading at $16.96, which is significantly above the GF Value™ estimate of $13.12, representing a 29.3% overvaluation. This disparity indicates that investors may be paying a premium for the stock compared to its intrinsic value. With the GF Valuation label identifying the stock as "Modestly Overvalued," it suggests that the current market price does not adequately reflect the company's underlying fundamentals.

Given that the stock is trading above its GF Value™, there is a risk for potential investors, as overvaluation can lead to price corrections. The margin of safety is limited, and investors may want to exercise caution before entering a position in MIR, as the stock may not provide a favorable risk-reward profile at this time. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.

How Does MIR's Valuation Compare to Its History? MetricCurrentHistorical P/E (TTM)188.4x225.9x (5-Year Median) Forward P/E31.5xN/A The current P/E (TTM) of 188.4x is significantly below its 5-year median of 225.9x, indicating that the stock is trading at a lower valuation relative to its historical performance. Additionally, the forward P/E of 31.5x shows a more favorable outlook compared to the current P/E. This analysis aligns with the GF Value™ verdict, suggesting that while the stock is overvalued, it may not be as stretched compared to its historical averages. Investors should take this into consideration when evaluating the stock's potential.

What Does MIR's GF Score™ Tell Us? MetricRating GF Score™54 Financial Strength5/10 Profitability3/10 Growth0/10 Valuation5/10 Momentum5/10 The GF Score™ of 54/100 indicates a performance level that is average when compared to other stocks. The strongest area is Financial Strength, which scored 5/10, suggesting a decent foundation. However, the weakest area is Growth, with a score of 0/10, indicating that the company has not demonstrated significant growth potential recently. The scores collectively highlight the need for caution, particularly in terms of profitability and growth, which are critical for long-term success.

What Are Insiders Doing with MIR Stock? In the past three months, insiders at Mirion Technologies have sold approximately $0.2 million worth of shares, with no reported insider buying during this period. This trend of selling may suggest that those closest to the company lack confidence in its near-term prospects or believe that the stock is currently overvalued. Such activity can serve as a warning signal for potential investors, indicating that insiders may not see opportunities for significant appreciation in the short term.

What This Means for Investors Based on the assessment of GF Value™, Mirion Technologies Inc MIR is considered overvalued at its current price of $16.96. This overvaluation, combined with average GF Score™ metrics and recent insider selling, suggests that investors may want to be cautious. Without a clear margin of safety, the stock may not provide an attractive entry point at present.

For the complete analysis, visit the Mirion Technologies Inc MIR stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.

Frequently Asked Questions What is MIR's GF Score™?

MIR's GF Score™ is 54/100, indicating an average performance based on key financial metrics.

Is MIR overvalued or undervalued?

MIR is currently overvalued with a GF Value™ estimate of $13.12 compared to its market price of $16.96.

What is MIR's P/E ratio?

MIR's P/E (TTM) is 188.4x, which is below its 5-year median of 225.9x, suggesting it is trading at a lower valuation relative to its historical levels.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].